Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Mirati Therapeutics Inc. buy Global_Player

Mirati Therapeutics Inc.
Start price
€56.50
07.12.22 / 50%
Target price
-
07.12.23
Performance (%)
-30.27%
End price
€39.40
10.12.22
Summary
This prediction ended on 10.12.22 with a price of €39.40. Massive losses of -30.27% were the result for the BUY prediction by Global_Player. Global_Player has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Mirati Therapeutics Inc. - - - -
iShares Core DAX® 2,57 % 5,33 % 8,27 % 63,86 %
iShares Nasdaq 100 4,86 % 0,45 % 27,08 % 86,27 %
iShares Nikkei 225® 5,59 % -0,59 % 48,55 % 78,35 %
iShares S&P 500 3,25 % 2,50 % 23,35 % 68,71 %

According to Global_Player what are the pros and cons of Mirati Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by Global_Player for this prediction

In the thread Mirati Therapeutics Inc. diskutieren

Buy Mirati Therapeutics Inc.

Global_Player 
0
Report Share
07.12.22 Buy -30.27%
In the thread Trading Mirati Therapeutics Inc.
Prediction Buy
Perf. (%) -30.27%
Target price
Change
Ends at 07.12.23

Buy beendet

Global_Player 
0
Report Share
10.12.22

Stopped prediction by Global_Player for Mirati Therapeutics Inc.

buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€59.10
05.10.23
-
05.10.24
-8.93%
15.10.23

Could be worthwhile Investment >10% per year
Global_Player 
05.10.23 50%